75th anniversary of the British Journal of Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Works matching IS 00070920 AND DT 2023 AND VI 128 AND IP 3
Results: 23
1
2
Diagnosing cancer earlier: what progress is being made?
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 441, doi. 10.1038/s41416-023-02171-8
- By:
- Publication type:
- Article
3
Tamoxifen evolution.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 421, doi. 10.1038/s41416-023-02158-5
- By:
- Publication type:
- Article
4
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 439, doi. 10.1038/s41416-023-02146-9
- By:
- Publication type:
- Article
5
Synthetic miR-34a against solid tumours: a predictable failure.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 478, doi. 10.1038/s41416-022-02123-8
- By:
- Publication type:
- Article
6
Tumour-infiltrating lymphocytes: from prognosis to treatment selection.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 451, doi. 10.1038/s41416-022-02119-4
- By:
- Publication type:
- Article
7
Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 413, doi. 10.1038/s41416-022-02109-6
- By:
- Publication type:
- Article
8
Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 419, doi. 10.1038/s41416-022-02075-z
- By:
- Publication type:
- Article
9
Large tumour-derived extracellular vesicles as prognostic indicators of metastatic cancer patient survival.
- Published in:
- 2023
- By:
- Publication type:
- journal article
10
The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England.
- Published in:
- 2023
- By:
- Publication type:
- journal article
11
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective.
- Published in:
- 2023
- By:
- Publication type:
- journal article
12
REMARK guidelines for tumour biomarker study reporting: a remarkable history.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 443, doi. 10.1038/s41416-022-02046-4
- By:
- Publication type:
- Article
13
Progress and priorities in reducing the time to cancer diagnosis.
- Published in:
- 2023
- By:
- Publication type:
- journal article
14
How the histological structure of some lung cancers shaped almost 70 years of radiobiology.
- Published in:
- 2023
- By:
- Publication type:
- journal article
15
The importance of long-term follow up of participants in clinical trials.
- Published in:
- 2023
- By:
- Publication type:
- journal article
16
Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104–111).
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 446, doi. 10.1038/s41416-022-02034-8
- By:
- Publication type:
- Article
17
50 years on and still very much alive: 'Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics'.
- Published in:
- 2023
- By:
- Publication type:
- journal article
18
Comment on "The lingering mysteries of metastatic recurrence in breast cancer".
- Published in:
- 2023
- By:
- Publication type:
- journal article
19
Age distribution and a multi-stage theory of carcinogenesis: 70 years on.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 404, doi. 10.1038/s41416-022-02009-9
- By:
- Publication type:
- Article
20
Intratumour heterogeneity, from hypothesis to the clinic.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 459, doi. 10.1038/s41416-022-02008-w
- By:
- Publication type:
- Article
21
Koller and the dawn of cancer cytogenetics.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 402, doi. 10.1038/s41416-022-01996-z
- By:
- Publication type:
- Article
22
The diagnostic breathprint of cancer; the past and the future.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 448, doi. 10.1038/s41416-022-01987-0
- By:
- Publication type:
- Article
23
Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer".
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 3, p. 461, doi. 10.1038/s41416-022-01960-x
- By:
- Publication type:
- Article